BioSpace News Archive

MorphoSys AG announced that Dr. Markus Enzelberger, the company’s Chief Scientific Officer, has decided to step down as CSO and member of the company’s Management Board to explore new opportunities. Dr. Enzelberger will leave MorphoSys on February 29, 2020.

BioSig Technologies, Inc. announced that the Company commenced its first clinical trial for its PURE EP™ System.

Masimo announced that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers at Nippon Medical School in Tokyo, Japan used Masimo Patient SafetyNet™ and rainbow Acoustic Monitoring®, acoustic respiration rate monitoring with RRa®, as a centralized continuous monitoring system to identify the incidence and predictors of desaturation and bradypnea in postoperative patients

SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Pharmaceutical Drug Development Services Market - Procurement Intelligence Report.

ROADM technology and ALM fiber monitoring solution ensure reliable, high-capacity connectivity across Finland

Immune-Onc Therapeutics, Inc. is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients.

SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Drug Intermediates and APIs Market - Procurement Intelligence Report.

Araim Pharmaceuticals, Inc. is pleased to announce the appointment of Ferdinand “Ferry” Breedveld, MD, PhD, the Chairman of the Board at Araim, as the organization’s acting Chief Executive Officer.

Inotrem S.A. announced it has initiated its Phase IIb ASTONISH trial to evaluate nangibotide in the treatment of septic shock and has enrolled the first patient in the trial.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present at the NeoAg Summit US 2019 in Boston on November 21st at 9:15 AM EST.